NIH working to 'quell' KPC superbug spread after 7th death reported
This article was originally published in Scrip
Executive Summary
The US National Institutes of Health (NIH) on 17 September said it is taking every measure possible to protect patients at its Clinical Center in Bethesda, Maryland, and quell transmission of a deadly antibiotic-resistant "superbug," known as Klebsiella pneumoniae carbapenemase (KPC), after a seventh person has succumbed to the infection.